Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB) - Takeaways - MDSpire

Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB)

  • By

  • Mohamed Abdul Moneim El Masry

  • Islam Abdul Rahman

  • Mohamed Fathy Mahmoud Elshal

  • Ahmed Maher Abdul Moneim

  • November 9, 2024

  • 0 min

Share

  • 1

    Obesity is a global health crisis, and metabolic/bariatric surgery is the most effective treatment for obesity and its related conditions.

  • 2

    Roux-en-Y gastric bypass (RYGB) is considered a gold standard for bariatric procedures due to its significant metabolic effects.

  • 3

    One anastomosis gastric bypass (OAGB) is gaining popularity for its simplicity and effectiveness, with potential benefits exceeding those of RYGB.

  • 4

    Diverted one-anastomosis gastric bypass (D-OAGB) aims to reduce bile reflux complications associated with OAGB by incorporating Roux-en-Y diversion.

  • 5

    This study compares mid-term outcomes of RYGB, OAGB, and D-OAGB, focusing on weight loss, adverse events, and improvement of obesity-related conditions.

Original Source(s)

Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB)

  • by Mohamed Abdul Moneim El Masry, Islam Abdul Rahman, Mohamed Fathy Mahmoud Elshal, Ahmed Maher Abdul Moneim

  • November 9, 2024

Related Content

Publisher Correction: Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease

The Impact of Metabolic Bariatric Surgery on Inflammatory Bowel Disease Risk and Outcomes in Adults With Obesity: a Propensity-matched, Nationwide, Analysis

Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions